Celebrating a Milestone: Advancing Precision MedTech 🇹🇼🇯🇵
Congratulations to Rakuten Medical on your latest breakthrough!
At NEXUS CVC, we are proud to support your advanced precision MedTech platform. This milestone highlights the strength of Taiwan-Japan collaboration and brings us closer to Rakuten Group founder Hiroshi Mikitani’s vision: conquering cancer through cutting-edge innovation.
We look forward to more breakthroughs from Rakuten Medical to benefit the world!
Rakuten Medical Raises $100 Million in Oversubscribed Series F to Accelerate Development Toward U.S. Regulatory Approval
-
Celebrating a Milestone: Advancing Precision MedTech 🇹🇼🇯🇵
-
NEXUS CVC Partners Recognized as One of Taiwan’s Private Equity Firms of the Year
-
NEXUS CVC leads investment in AI Company CloudMile Deepening AI technology applications and expanding International Market
-
Heartfelt congratulations to AMBIQ on its successful listing on the New York Stock Exchange (NYSE).
-
NEXUS CVC congratulates CapsoVision on its successful NASDAQ IPO!